Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy

Mutations in SYNGAP1 are associated with developmental delay, epilepsy, and autism spectrum disorder (ASD). Epilepsy is often drug‐resistant in this syndrome with frequent drop attacks. In a prospective study of add‐on cannabidiol (CBD), we identified three patients with SYNGAP1 mutations: two boys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchenbuch, Mathieu, D'Onofrio, Gianluca, Chemaly, Nicole, Barcia, Giulia, Teng, Théo, Nabbout, Rima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469777/
https://www.ncbi.nlm.nih.gov/pubmed/32913957
http://dx.doi.org/10.1002/epi4.12411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469777/
https://www.ncbi.nlm.nih.gov/pubmed/32913957
http://dx.doi.org/10.1002/epi4.12411

Ejemplares similares